The catalyst that drove 2015's increase, I believe, was news of the deal with Shenzhen Hepalink.  Hepalink is a major Chinese Pharma Co and the world's largest producer of Heparin Sodium, a blood thinner.  Now of course they're Resverlogix's biggest shareholder at over 40%....I'm not 100% certain of that, but darn near...99.9999

I'm seeing about 23 odd thousand trading so far today...which I imagine is less shares than many in this forum individually own.  

I haven't been posting much at all so I'm going to ramble a bit.

As far as the Pfizer/Zenith collabation providing some validation.  In my opinion we already had that validation a while back when Pfizer included Apabetalone in a patent application for the treatment of orphan disease Friedreich's Ataxia (sp?).

On the financing side....it seems to me that Don is content to simply keep the company's coffers topped up "just enough" to meet obligations and to meet Third Eye loan covenants.  Its like when I'm driving back from Quebec, I only want enough gas in my van to get me to the Ontario border because I know its more financially advantageous (less expensive) to fill up in Alexandria than in Montreal.  

There have been comments before about how DM is not willing to "give it away" when it comes to Apabetalone or Resverlogix as a whole.  Of course we don't know what kind of dollar figures are rolling around in his head....or if there have been any concrete offers with actual amounts.  If some BP was willing to pay say $5 billion USD for Apabetalone, would DM consider that as too low?  

I'm heading to the Carribean in January for a week, and I hope to be significantly richer, ( at least on paper) before we hop on the plane.